Beam Therapeutics: Single-Base Editing Seems To Work
The author is looking forward to seeing how Beam Therapeutics would do in their clinical trials of single-base DNA editing.
BioPharma Dive12d
Beam base editing therapy gets ‘proof of concept’ in rare lung disease
While initial study results suggest Beam's technology can correct alpha-1 antitrypsin deficiency's genetic roots, shares fell ...
Hosted on MSN2mon
Neutrophil elastase test shows promise in predicting preterm birth
No previous study has been conducted in Nigeria on the role of neutrophil elastase in predicting preterm birth. The present study aimed to determine the role of the neutrophil elastase test in ...
Beam Therapeutics announces ‘positive’ data from study of BEAM-302
Beam Therapeutics (BEAM) announced initial safety and efficacy data from its Phase 1/2 trial of BEAM-302, establishing clinical ...